NIH Consensus Conference.Adjuvant therapy for patients with colon and rectal cancer.JAMA1990; 264: 1444–50.
2.
HolmT., RutqvistL.E., JohanssonH., CedermarkB.Abdominoperineal resection and anterior resection in the treatment of rectal cancer: results in relation to adjuvant preoperative radiotherapy.Br J Surg1995; 82: 1213–6.
3.
WillettC., WarlandG., HaganM.. Tumor proliferation in rectal cancer following preoperative irradiation.J Clin Oncol1995; 13: 1417–24.
4.
EnriquezJ.M., MartienzP., PerezJ.. Efecto de la radioterapia preoperatoria en la detección de las metástasis ganglionares del cancer de recto.Rev Esp Enf Dig1993; 83: 345–9.
5.
DiezM., EnriquezJ.M., CamuñasJ.. Prediction of recurrence in B-C stages of colorectal cancer by p53 protein nuclear expression in comparison with standard pathological features.Eur J Surg Oncol1995; 21: 635–9.
6.
AraiT., KidaY., HarmonB.V., GobeG.C.Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine.Br J Cancer1996; 74: 406–12.
7.
SilesE., VillalobosM., ValenzuelaM.T.. Relationship between p53 status and radiosensitivity in human tumour cell lines.Br J Cancer1996; 73: 581–8.
8.
ChangF., SyrjänenS., SyrjänenK.Implications of the p53 tumor-suppressor gene in clinical oncology.J Clin Oncol1995; 13: 1009–22.
9.
DesaiG.R., MyersonR.J., HigashikuboR.. Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy.Dis Colon Rectum1996; 39: 1090–6.
10.
WatsonA.J.M., MerritA.J., JonesL.S.. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.Br J Cancer1996; 73: 889–95.
11.
TeixeiraC., TanakaS., HarumaK., YoshiharaM., SumiiK., KajiyamaG.Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas.Cancer1994; 73: 575–9.
